1.15

7.48% 0.08

After Hours: 1.12 -0.03 -2.61%

22nd Century Group, Inc. (XXII)

Overview News Price History Option Chain Discussions Forecast Stock Split

22nd Century Group, Inc. stock is traded at $1.15, with a volume of 609.98K. It is up +7.48% in the last 24 hours and up +29.20% over the past month. 22nd Century Group, Inc., a plant biotechnology company, provides technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and cannabinoids in hemp/cannabis plants through genetic engineering and plant breeding. It offers premium cigarettes under the RED SUN and MAGIC brands; and SPECTRUM, a line of research cigarettes for use in independent clinical studies. The company's products under development include BRAND A, a very low nicotine cigarette; X-22, a tobacco-based botanical medical product for use as an aid to smoking cessation; and BRAND B, a low-tar-to-nicotine ratio cigarette. In addition, it engages in contract manufacturing business for third-party branded tobacco products. The company has scientific collaborations with the University of Virginia and Anandia Laboratories, Inc. to develop proprietary hemp strains with less than 0.3% dry weight content of delta-9-tetrahydrocannabinol. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Williamsville, New York.

Previous Close:

$1.07

Open:

$1.09

24h Volume:

609.98K

Relative Volume:

0.90

Market Cap:

$4.87M

Revenue:

$29.78M

Net Income/Loss:

$-39.94M

P/E Ratio:

-0.0186

EPS:

-61.9139

Net Cash Flow:

$-16.12M

1W Performance:

-3.36%

1M Performance:

+29.20%

6M Performance:

-91.47%

1Y Performance:

-99.45%

1-Day Range:

$1.01

$1.2599

1-Week Range:

$1.01

$1.3195

52-Week Range:

$0.70

$221.40

22nd Century Group, Inc. Stock (XXII) Company Profile

Name

22nd Century Group, Inc.

Sector

Healthcare (1148)

Industry

Biotechnology (665)

Phone

716-270-1523

Address

8560 Main Street, Williamsville, NY

Employee

Twitter

@_xxiicentury

Next Earnings Date

2024-12-12

Latest SEC Filings

XXII's Discussions on Twitter

Compare XXII with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
XXII 22nd Century Group, Inc.	1.15	4.87M	29.78M	-39.94M	-16.12M	-61.91
VRTX Vertex Pharmaceuticals Inc	432.00	115.57B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	574.16	60.30B	14.09B	4.50B	2.96B	39.28
ARGX Argen X Se Adr	542.47	37.56B	2.58B	1.06B	-1.28B	16.33
ALNY Alnylam Pharmaceuticals Inc	266.86	35.18B	2.35B	-269.70M	-75.39M	-2.09
ONC Beigene Ltd Adr	224.73	26.10B	3.81B	-644.79M	-669.77M	-6.24

22nd Century Group, Inc. Stock (XXII) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-21-22	Initiated	Alliance Global Partners	Buy
Jun-15-22	Initiated	Craig Hallum	Buy
Mar-08-22	Initiated	ROTH Capital	Buy
Jul-23-21	Initiated	Cowen	Outperform
Oct-16-17	Reiterated	Chardan Capital Markets	Buy
Aug-11-16	Reiterated	Chardan Capital Markets	Buy

View All

22nd Century Group, Inc. Stock (XXII) Latest News

02:32 AM

Earnings call transcript: 22nd Century Group Reports Q1 2025 Revenue Surge - Investing.com Australia

02:32 AM

07:23 AM

22nd Century Group Reports 50% Sequential Sales Increase in First Quarter 2025, Advances Growth Strategy and New Product Launches - Nasdaq

06:10 AM

May 11, 2025